BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32662449)

  • 1. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breath Biomarkers in Diagnostic Applications.
    Pham YL; Beauchamp J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath biopsy: a new cancer detection paradigm.
    Abderrahman B
    Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.
    Mellors TR; Nasir M; Franchina FA; Smolinska A; Blanchet L; Flynn JL; Tomko J; O'Malley M; Scanga CA; Lin PL; Wagner J; Hill JE
    J Breath Res; 2018 Oct; 13(1):016004. PubMed ID: 29910196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A breath sampling system assessing the influence of respiratory rate on exhaled breath composition.
    Lomonaco T; Salvo P; Ghimenti S; Biagini D; Bellagambi F; Fuoco R; Di Francesco F
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():7618-21. PubMed ID: 26738056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pursuing breath research in unprecedented circumstances-report from the Breath Biopsy Conference 2020.
    Lawson J; Beauchamp J
    J Breath Res; 2021 Jun; 15(3):. PubMed ID: 34107459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled breath condensate biomarkers for lung cancer.
    Campanella A; De Summa S; Tommasi S
    J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications.
    Khoubnasabjafari M; Mogaddam MRA; Rahimpour E; Soleymani J; Saei AA; Jouyban A
    Crit Rev Anal Chem; 2022; 52(7):1461-1487. PubMed ID: 33691552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data.
    Ruzsányi V; Kalapos MP
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37433292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes noninvasive diagnostics and monitoring through volatile biomarkers analysis in the exhaled breath using optical absorption spectroscopy.
    Kistenev YV; Borisov AV; Zasedatel VS; Spirina LV
    J Biophotonics; 2023 Dec; 16(12):e202300198. PubMed ID: 37643222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.